LSA
CGEM icon

Leonteq Securities AG’s Cullinan Oncology CGEM Stock Holding History

Leonteq Securities AG’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$546K Buy
30,000
+20,000
+200% +$297K 0.02% 389
2026
Q1 		$142K Buy
+10,000
New +$129K 0.01% 666
2022
Q4 		– Sell
-5,000
Closed -$64.1K – 1303
2022
Q3 		$64.1K Hold
5,000
– – ﹤0.01% 747
2022
Q2 		$64.1K Buy
5,000
+1,000
+25% +$11.3K ﹤0.01% 772
2022
Q1 		$41.9K Buy
+4,000
New +$54K ﹤0.01% 894

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Leonteq Securities AG's CGEM Position: Q2 2026 in Review

Leonteq Securities AG increased its Cullinan Oncology (CGEM) stake by 200% in Q2 2026, buying an estimated $297K and bringing the position to 30,000 shares worth $546K. The position accounts for 0.02% of the portfolio, ranked #389.

Leonteq Securities AG first reported a position in CGEM in Q1 2022 and has held it in 5 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Leonteq Securities AG held 30,000 shares of Cullinan Oncology worth $546K as of Q2 2026.
  • Leonteq Securities AG bought 20,000 Cullinan Oncology shares in Q2 2026, an estimated $297K.
  • Cullinan Oncology made up 0.02% of Leonteq Securities AG's portfolio in Q2 2026, its #389 holding.
  • Leonteq Securities AG first reported a position in Cullinan Oncology in Q1 2022 and has held it in 5 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.